Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review
Open accessThe DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Purpose: To summarize available evidence comparing the transdermal and the oral administration routes of hormone replacement therapy (HRT) in postmenopausal women. Methods: We performed a systematic review of the literature on multiple databases between January 1990 and December 2021. We included randomized controlled trials and observational studies comparing the transdermal and oral administration routes of estrogens for HRT in postmenopausal women regarding at least one of the outcomes of interest: cardiovascular risk, venous thromboembolism (VTE), lipid metabolism, carbohydrate metabolism, bone mineral density (BMD), and risk of pre-malignant and malignant endometrial lesions, or breast cancer. Results: The systematic literature search identified a total of 1369 manuscripts, of which 51 were included. Most studies were observational and of good quality, whereas the majority of randomized controlled trials presented a high or medium risk of bias. Oral and transdermal administration routes are similar regarding BMD, glucose metabolism, and lipid profile improvements, as well as do not appear different regarding breast cancer, endometrial disease, and cardiovascular risk. Identified literature provides clear evidence only for the VTE risk, which is higher with the oral administration route. Conclusions: Available evidence comparing the transdermal and oral administration routes for HRT is limited and of low quality, recommending further investigations. VTE risk can be considered the clearest and strongest clinical difference between the two administration routes, supporting the transdermal HRT as safer than the oral administration route.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“observational studies reveal the potential for reduced risk for thromboembolism and dyslipidemia with transdermal delivery when compared to oral (209, 210).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [210]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Practice Bulletin No. 141 Management of Menopausal Symptoms
(2014) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000441353.20693.78 · Cited by 434
RetractedRoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments
Lo, C. K.-L., Mertz, D., & Loeb, M. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-45 · Cited by 2,477
Mosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. M., Newby, L. K., Piña, I. L., Roger, V. L., Shaw, L. J., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820faaf8 · Cited by 2,143
Stewart, L. A., Clarke, M., Rovers, M., Riley, R. D., Simmonds, M., Stewart, G., & Tierney, J. F. (2015) · JAMA · doi:10.1001/jama.2015.3656 · Cited by 2,134 · cited 1×
“Analyses (PRISMA) statement for transparent reporting of systematic reviews and meta-analyses [11].”
MethodCauley, J. A. (2003) · JAMA · doi:10.1001/jama.290.13.1729 · Cited by 1,221
Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble
Kontis, V., Bennett, J. E., Mathers, C. D., Li, G., Foreman, K., & Ezzati, M. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32381-9 · Cited by 1,219
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Canonico, M., Oger, E., Plu-Bureau, G., Conard, J., Meyer, G., Lévesque, H., Trillot, N., Barrellier, M.-T., Wahl, D., Emmerich, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.642280 · Cited by 864
Risk of venous thromboembolism in users of hormone replacement therapy
Daly, E., Vessey, M. P., Hawkins, M. M., Carson, J. L., Gough, P., & Marsh, S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07113-9 · Cited by 819
Premature menopause or early menopause: Long-term health consequences
Shuster, L. T., Rhodes, D. J., Gostout, B. S., Grossardt, B. R., & Rocca, W. A. (2010) · Maturitas · doi:10.1016/j.maturitas.2009.08.003 · Cited by 808
Scarabin, P.-Y., Oger, E., & Plu-Bureau, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14066-4 · Cited by 714
Fournier, A., Berrino, F., & Clavel-Chapelon, F. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9523-x · Cited by 693
Long term hormone therapy for perimenopausal and postmenopausal women
Farquhar, C., Marjoribanks, J., Lethaby, A., Suckling, J. A., & Lamberts, Q. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004143.pub2 · Cited by 582
Canonico, M., Plu-Bureau, G., Lowe, G. D. O., & Scarabin, P.-Y. (2008) · BMJ · doi:10.1136/bmj.39555.441944.be · Cited by 569
WEISSBERGER, A. J., HO, K. K. Y., & LAZARUS, L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-374 · Cited by 514
Recent trends in life expectancy across high income countries: retrospective observational study
Ho, J. Y., & Hendi, A. S. (2018) · BMJ · doi:10.1136/bmj.k2562 · Cited by 439 · cited 1×
“Women’s life expectancy has increased by almost 10 years over the past half-century and is now approximately 78–86 years in most European countries [1, 2].”
BackgroundVinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2019) · BMJ · doi:10.1136/bmj.k4810 · Cited by 433
Fournier, A., Berrino, F., Riboli, E., Avenel, V., & Clavel‐Chapelon, F. (2005) · International Journal of Cancer · doi:10.1002/ijc.20710 · Cited by 403
Weight Gain at the Time of Menopause
Wing, R. R. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400010111016 · Cited by 393
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women
Cho, L., Davis, M., Elgendy, I., Epps, K., Lindley, K. J., Mehta, P. K., Michos, E. D., Minissian, M., Pepine, C., Vaccarino, V., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.060 · Cited by 347
Hormone replacement therapy and risk of venous thromboembolism: population based case-control study
Gutthann, S. P., Rodriguez, L. A. G., Castellsague, J., & Oliart, A. D. (1997) · BMJ · doi:10.1136/bmj.314.7083.796 · Cited by 338
The Controversial History of Hormone Replacement Therapy
Cagnacci, A., & Venier, M. (2019) · Medicina · doi:10.3390/medicina55090602 · Cited by 298
Stevenson, J. C., Cust, M. P., Gangar, K. F., Hillard, T. C., Lees, B. L., Cust, M. P., Gangar, K. F., Hillard, T. C., & Whitehead, M. I. (1990) · The Lancet · doi:10.1016/0140-6736(90)91801-g · Cited by 278
Long term hormone therapy for perimenopausal and postmenopausal women
Marjoribanks, J., Farquhar, C., Roberts, H., & Lethaby, A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004143.pub4 · Cited by 278
Canonico, M., Fournier, A., Carcaillon, L., Olié, V., Plu-Bureau, G., Oger, E., Mesrine, S., Boutron-Ruault, M.-C., Clavel-Chapelon, F., & Scarabin, P.-Y. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.196022 · Cited by 272
DAWSON-HUGHES, B., STERN, D., GOLDMAN, J., & REICHLIN, S. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-424 · Cited by 249
Godsland, I. F., Gangar, K., Walton, C., Cust, M. P., Whitehead, M. I., Wynn, V., & Stevenson, J. C. (1993) · Metabolism · doi:10.1016/0026-0495(93)90058-v · Cited by 213
O'Sullivan, A. J., Crampton, L. J., Freund, J., & Ho, K. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2773 · Cited by 210
SWEETLAND, S., BERAL, V., BALKWILL, A., LIU, B., BENSON, V. S., CANONICO, M., GREEN, J., & REEVES, G. K. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04919.x · Cited by 208
Hormone replacement therapy and the risk of venous thromboembolism: a population-based study
RENOUX, C., Dell'ANIELLO, S., & SUISSA, S. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03839.x · Cited by 208
Straczek, C., Oger, E., Yon de Jonage-Canonico, M. B., Plu-Bureau, G., Conard, J., Meyer, G., Alhenc-Gelas, M., Lévesque, H., Trillot, N., Barrellier, M.-T., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.565556 · Cited by 200
Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy
Lyytinen, H., Pukkala, E., & Ylikorkala, O. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31818e8cd6 · Cited by 199
Revised Global Consensus Statement on Menopausal Hormone Therapy
de Villiers, T. J., Hall, J. E., Pinkerton, J. V., Cerdas Pérez, S., Rees, M., Yang, C., & Pierroz, D. D. (2016) · Climacteric · doi:10.1080/13697137.2016.1196047 · Cited by 198
Prognostic Factors for Uterine Cancer in Reproductive-Aged Women
Lee, N. K., Cheung, M. K., Shin, J. Y., Husain, A., Teng, N. N., Berek, J. S., Kapp, D. S., Osann, K., & Chan, J. K. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000255980.88205.15 · Cited by 196
Management of Menopausal Symptoms
Kaunitz, A. M., & Manson, J. E. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001058 · Cited by 191
Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis
Mohammed, K., Abu Dabrh, A. M., Benkhadra, K., Al Nofal, A., Carranza Leon, B. G., Prokop, L. J., Montori, V. M., Faubion, S. S., & Murad, M. H. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2237 · Cited by 183
Santen, R. J. (2015) · Climacteric · doi:10.3109/13697137.2014.947254 · Cited by 181
Thompson, J. L. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.6.1845 · Cited by 159
Breast Cancer Risk in Postmenopausal Women Using Estrogen-Only Therapy
Lyytinen, H., Pukkala, E., & Ylikorkala, O. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000241091.86268.6e · Cited by 153
Varas-Lorenzo, C., García-Rodríguez, L. A., Perez-Gutthann, S., & Duque-Oliart, A. (2000) · Circulation · doi:10.1161/01.cir.101.22.2572 · Cited by 150
Hormone therapy and risk of myocardial infarction: a national register study
Lokkegaard, E., Andreasen, A. H., Jacobsen, R. K., Nielsen, L. H., Agger, C., & Lidegaard, O. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn408 · Cited by 120
Rovinski, D., Ramos, R. B., Fighera, T. M., Casanova, G. K., & Spritzer, P. M. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.06.014 · Cited by 115
Hormone replacement therapy use and variations in the risk of breast cancer
Opatrny, L., Dell’Aniello, S., Assouline, S. E., & Suissa, S. (2007) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01520.x · Cited by 108
Armeni, E., Lambrinoudaki, I. V., Ceauşu, I., Depypere, H. T., Mueck, A. O., Pérez-López, F. R., van der Schouw, Y. T., Senturk, L. M., Simoncini, T., Stevenson, J. C., et al. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.04.013 · Cited by 102
Kopper, N., Gudeman, J., & Thompson, D. (2008) · Drug Design Development and Therapy · doi:10.2147/dddt.s4146 · Cited by 96
Dr. Ho, K. K. Y., & Weissberger, A. J. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070711 · Cited by 91 · cited 1×
“GH and IGF-I play a pivotal role in body composition and in resting energy expenditure and finally influence glucose metabolism [77, 78].”
BackgroundBergendal, A., Kieler, H., Sundström, A., Hirschberg, A. L., & Kocoska-Maras, L. (2016) · Menopause · doi:10.1097/gme.0000000000000611 · Cited by 90
Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women
Gabriel Sanchez, R., Sanchez Gomez, L. M., Carmona, L., Roqué i Figuls, M., & Bonfill Cosp, X. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002229.pub2 · Cited by 87
de Lauzon-Guillain, B., Fournier, A., Fabre, A., Simon, N., Mesrine, S., Boutron-Ruault, M.-C., Balkau, B., & Clavel-Chapelon, F. (2009) · Diabetologia · doi:10.1007/s00125-009-1456-y · Cited by 86 · cited 3×
“Another study was not able to show significant differences between the progestogens used in the HRT [41].”
BackgroundInfluentialHodis, H. N., & Mack, W. J. (2011) · Brain Research · doi:10.1016/j.brainres.2010.10.076 · Cited by 83
Chu, M. C., Cosper, P., Nakhuda, G. S., & Lobo, R. A. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.04.043 · Cited by 82
Assessment of the climacteric syndrome: a narrative review
Sourouni, M., Zangger, M., Honermann, L., Foth, D., & Stute, P. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06139-y · Cited by 80
Reis, C., de Melo, N. R., Meirelles, E. S., Paranaguá‐Vezozzo, D. C., & Halpern, A. (2003) · Maturitas · doi:10.1016/s0378-5122(03)00159-2 · Cited by 79
Hemelaar, M., van der Mooren, M. J., Rad, M., Kluft, C., & Kenemans, P. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.07.1298 · Cited by 70
Wakatsuki, A., Okatani, Y., Ikenoue, N., & Fukaya, T. (2002) · Circulation · doi:10.1161/01.cir.0000032261.12632.d7 · Cited by 70
Whitcroft, S. I. J., Crook, D., Marsh, M. S., Ellerington, M. C., Whitehead, M., & Stevenson, J. C. (1994) · PubMed · Cited by 69
Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation
Corrao, G., Zambon, A., Conti, V., Nicotra, F., Vecchia, C. L., Fornari, C., Cesana, G., Contiero, P., Tagliabue, G., Nappi, R. E., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm404 · Cited by 65
Simon, J. A., Laliberté, F., Duh, M. S., Pilon, D., Kahler, K. H., Nyirady, J., Davis, P. J., & Lefèbvre, P. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000590 · Cited by 60
Goodman, N. F., Cobin, R. H., Ginzburg, S. B., Katz, I. A., Woode, D. E., Camacho, P. M., Manson, J. E., & Petak, S. M. (2011) · Endocrine Practice · doi:10.4158/ep.17.6.949 · Cited by 58
ROSANO, G. M. C., VITALE, C., & FINI, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.031 · Cited by 55
Adami, S., Rossini, M., Zamberlan, N., Bertoldo, F., Dorizzi, R., & Lo Cascio, V. (1993) · Maturitas · doi:10.1016/0378-5122(93)90046-k · Cited by 54
Chilvers, C. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.09.019 · Cited by 46
Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism
Karjalainen, A., Paassilta, M., Heikkinen, J., Bäckström, A., Savolainen, M., & Kesäniemi, Y. A. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01208.x · Cited by 44
Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations
Mattsson, L. (1999) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00225-2 · Cited by 39
Percutaneous 17β-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women
Archer, D. F. (2003) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000070526.74726.8a · Cited by 37
Spencer, C., Crook, D., Ross, D., Cooper, A. J., Whitehead, M. I., & Stevenson, J. C. (1999) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1999.tb08435.x · Cited by 33
Cetinkaya, M. B., Kökçü, A., Yanık, F. F., Başoğlu, T., Malatyalıoğlu, E., & Alper, T. (2002) · Journal of Bone and Mineral Metabolism · doi:10.1007/s774-002-8446-8 · Cited by 32
Erenus, M., Karakoç, B., & Gürler, A. (2001) · Climacteric · doi:10.1080/cmt.4.3.228.234 · Cited by 26
A Review of Transdermal Nonpatch Estrogen Therapy for the Management of Menopausal Symptoms
Carroll, N. (2010) · Journal of Women s Health · doi:10.1089/jwh.2008.1206 · Cited by 25
Donato, V. D., Palaia, I., D’Aniello, D., Musacchio, L., Santangelo, G., mauro, F. D., Pinto, A. D., Musella, A., Fischetti, M., Tomao, F., et al. (2020) · Oncology · doi:10.1159/000505427 · Cited by 24
Samsioe, G., Dvorak, V., Genazzani, A. R., Bernd Hamann, A., Heikkinen, J. E., Mueck, A. O., Suzin, J., Kawakami, F. T., Ferreira, A., Sun, D., et al. (2007) · Maturitas · doi:10.1016/j.maturitas.2007.01.001 · Cited by 22
Effects of Hormone Therapy on Serum Lipid Levels in Postmenopausal Korean Women
Lee, J.-Y., Hyun, H. S., Park, H.-G., Seo, J., Lee, E. Y., Lee, J. S., Lee, D., Choi, D. S., & Yoon, B.-K. (2015) · Journal of Menopausal Medicine · doi:10.6118/jmm.2015.21.2.104 · Cited by 22
Shakir, Y. A., Samsioe, G., Nerbrand, C., & Lidfeldt, J. (2004) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000133076.09175.6d · Cited by 21
Effects of percutaneous oestradiol versus oral oestrogens on bone density
Palacios, S., Menendez, C. E. E. A., Jurado, A. R., & Vargas, J. C. (1994) · Maturitas · doi:10.1016/0378-5122(94)90018-3 · Cited by 20
Christodoulakos, G., Lambrinoudaki, I. V., Economou, E. V., Papadias, C. B., Panoulis, C., Kouskouni, E. E., Vlachou, S. A., & Creatsas, G. C. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000211747.16573.d5 · Cited by 20
Myocardial infarction risk and hormone replacement: Differences between products
de Vries, C. S., Bromley, S. E., & Farmer, R. D. T. (2005) · Maturitas · doi:10.1016/j.maturitas.2005.06.004 · Cited by 19
Stute, P., Eversheim, H., Ortius‐Lechner, D., May, M., & Feig, C. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06457-9 · Cited by 15
Effect of daily hormone therapy and alendronate use on bone mineral density in postmenopausal women
Davas, İ., Altintas, A., Yoldemir, T., Varolan, A., Yazgan, A., & Baksu, B. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00757-x · Cited by 14
Effect of Transdermal Estrogen Therapy on Bone Mineral Density in Postmenopausal Korean Women
Kim, H. J., Oh, Y. K., Lee, J. S., Lee, D., Choi, D., & Yoon, B.-K. (2014) · Journal of Menopausal Medicine · doi:10.6118/jmm.2014.20.3.111 · Cited by 13
Perrone, G., Stefanutti, C., Galoppi, P., Anelli, G., Capri, O., Lucani, G., Vivenzio, A., Mazzarella, B., & Zichella, L. (1996) · PubMed · Cited by 12
Castelo‐Branco, C., & Soveral, I. (2014) · Research and Reports in Transdermal Drug Delivery · doi:10.2147/rrtd.s47532 · Cited by 11
A case-control study on the effect of hormone replacement therapy on ischaemic heart disease.
Hippisley‐Cox, J., Pringle, M., Crown, N., & Coupland, C. A. C. (2003) · Europe PMC (PubMed Central) · Cited by 9
What is behind the fear of cancer during menopausal hormone therapy in China?
Wang, Y., Wang, W., Feng, Y., Tan, Z., Yang, X., Peng, D., Zhao, Y., Dong, H., Zheng, Q., Zeng, X., et al. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06052-4 · Cited by 7
Şendağ, F., Terek, M. C., & Karadadaş, N. (2001) · Archives of Gynecology and Obstetrics · doi:10.1007/s004040100231 · Cited by 4
Collette, J., Viethel, P., Dethor, M., Chevallier, T., Micheletti, M. C., Foidart, J. M., & Reginster, J. (2003) · Gynécologie Obstétrique & Fertilité · doi:10.1016/s1297-9589(03)00118-8 · Cited by 4
Russu, M. C., Stănculescu, R. V., & Nastasia, S. I. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.02.217 · Cited by 1
Cited by
Management of Menopausal Symptoms: A Review
Crandall, C. J., Mehta, J. M., & Manson, J. E. (2023) · JAMA · doi:10.1001/jama.2022.24140 · Cited by 316
Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?
Cho, L., Kaunitz, A. M., Faubion, S. S., Hayes, S. N., Lau, E. S., Pristera, N., Scott, N., Shifren, J. L., Shufelt, C. L., Stuenkel, C. A., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.061559 · Cited by 205
Sex differences in lipids: a life course approach
Holven, K. B., & Roeters van Lennep, J. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117270 · Cited by 180
Managing menopause after cancer
Hickey, M., Basu, P. S., Sassarini, J., Stegmann, M., Weiderpass, E., Chilowa, K. N., Yip, C. H., Partridge, A. H., & Brennan, D. J. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02802-7 · Cited by 147
Lipid metabolism in women: A review
van Oortmerssen, J. A. E., Mulder, J. W. C. M., Kavousi, M., & van Lennep, J. E. R. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119213 · Cited by 83
Metadata
- Authors
- Goldštajn, M. Š., Mikuš, M., Ferrari, F. A., Bosco, M., Uccella, S., Noventa, M., Török, P., Terzic, S., Laganà, A. S., & Garzon, S.
- Affiliations
- University Hospital Centre Zagreb (HR)
- University of Verona (IT)
- University of Padua (IT)
- Nazarbayev University (KZ)
- University of Palermo (IT)
- Corresponding author
- Ferrari, Filippo Alberto
- ORCID
- Venue
- Archives of Gynecology and Obstetrics
- Published
- 2022-06-17
- Volume
- 307
- Issue
- 6
- Pages
- 1727-1745
- ISSN
- 0003-9128 (ISSN-L)
- 1432-0711
- PMC
- PMC10147786
- OpenAlex
- W4283032275
- Cited by
- 111
- References
- 91
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 29 · 2023: 20
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Archives of Gynecology and Obstetrics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Nazarbayev University Repository (Nazarbayev University) (submittedVersion, other-oa)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion, cc-by)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Funders
- Università degli Studi di Verona
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- hormone replacement therapy, transdermal estrogen, oral estrogen, postmenopausal women, venous thromboembolism, cardiovascular risk, bone mineral density, lipid metabolism, glucose metabolism, breast cancer risk, endometrial disease
- MeSH terms
- Administration, Cutaneous, Administration, Oral, Breast Neoplasms, Estrogens, Female, Humans, Lipids, Estrogen Replacement Therapy, Postmenopause, Hormone Replacement Therapy, Venous Thromboembolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
